UPDATE : Saturday, October 12, 2019
상단여백
'Daewoong risk' could put a damper on AbbVie-Allergan mega-merger
Daewoong Pharmaceutical's launch of Jeuveau, its botulinum toxin (BTX) ...
by Lee Han-soo  |  2019-08-07 16:22
라인
Lilly’s anticancer combo drug nears getting insurance benefit
Eli Lilly said its anticancer drug Verzenio showed an improvement in overal...
by Kim Yun-mi  |  2019-08-07 15:44
라인
Over 5,700 patients received Allergan’s breast implants linked to rare cancer
Health authorities around the world recently recalled Allergan’s breast imp...
by Song Soo-youn  |  2019-08-07 15:43
라인
[Reporter’s Notebook] SillaJen should be ashamed of itself
It was an obvious failure of a drug trial, but the drugmaker said it was no...
by Jeong Sae-im  |  2019-08-07 13:59
라인
Lilly reports improved survival for Verzenio in P3 trial
Eli Lilly Korea said that Verzenio (Ingredient: Abemaciclib) demonstrated a...
by Lee Han-soo  |  2019-08-07 12:06
라인
ISU Abxis to unveil p1 results for anticancer treatment in Europe
ISU Abxis will present its phase 1 clinical trial data for ISU104, an Erb-B...
by Lee Han-soo  |  2019-08-07 12:03
라인
Crystal Genomics signs accord with CRO firm
Crystal Genomics said that it has signed an agreement with PRA Health Scien...
by Lee Han-soo  |  2019-08-06 17:20
라인
Myongji Hospital opens sports medicine center
Myongji Hospital said that it has opened a new sports medicine center at th...
by Lee Han-soo  |  2019-08-06 16:54
라인
Japanese firms fear boycott may hurt prescription drug sales
Korean offshoots of Japanese pharmaceutical companies are worrying that the...
by Kim Yun-mi  |  2019-08-06 15:44
라인
Sillajen cites salvation therapy as reason for trial suspension advice
Sillajen said that it believes that the Independent Data Monitoring Committ...
by Lee Han-soo  |  2019-08-06 15:43
라인
HLB to seek pre-NDA meeting with FDA for rivoceranib
HLB said it would request for a pre-New Drug Application (NDA) meeting with...
by Jeong Sae-im  |  2019-08-06 15:43
라인
Market value of biopharmaceuticals drops ₩10 trillion on 'Black Monday'
Biopharmaceutical shares in the nation’s secondary bourse had their worst d...
by Lee Han-soo  |  2019-08-06 13:50
라인
Roche, MSD, AstraZeneca: top 3 risers on NASDAQ biotech
Roche, MSD (Merck in the U.S.), and AstraZeneca achieved the most significa...
by Kim Yun-mi  |  2019-08-06 11:29
라인
South Koreans learn to thank life by experiencing death
Some South Koreans are using an unorthodox method to appreciate life and co...
by Lee Han-soo  |  2019-08-06 06:00
라인
Pharmicell submits investigational new drug application for prostate cancer treatment
Pharmicell said that it has filed an investigational new drug application t...
by Lee Han-soo  |  2019-08-05 17:59
라인
Crystal Genomics confirms efficacy of inflammatory bowel disease treatment
Crystal Genomics said that it has confirmed the efficacy of CG-598, an infl...
by Lee Han-soo  |  2019-08-05 17:02
라인
Sillajen’s trouble heralds fall of one of most prominent biotech firms
Shares of Sillajen continued to take a nosedive Monday after the biotech fi...
by Lee Han-soo  |  2019-08-05 16:55
라인
Boycott of Japanese drug intensifies as Seoul-Tokyo relations worsen
With Japan deciding to remove South Korea from the list of trusted trading ...
by Lee Han-soo  |  2019-08-05 16:01
라인
Amgen’s lipid-lowering Repatha beats Sanofi’s Praluent in Q2 sales
Amgen won the battle against Sanofi in sales of cholesterol-lowering PCSK9 ...
by Kim Yun-mi  |  2019-08-05 15:37
라인
SillaJen remains confident about Pexa-Vec’s value, despite trial failure
SillaJen said Pexa-Vec, an oncolytic viral drug, still had significant pote...
by Jeong Sae-im  |  2019-08-05 14:49
여백
여백
여백
Back to Top